Treatment of glioma cells with the eEF2K inhibitor, NH125 (1), showed the enhancement of TRAIL-induced apoptosis, and, with the increase of dosed NH125, the cleaved PARP and caspase 8 levels increased significantly [45]. Here, EEF2K is linked to glioma.